Fig. 1From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationFormulation of nanoformulation after encapsulation of VC into thiolated chitosan with HA coating for targeted delivering in prostate cancer cells at CD44 siteBack to article page